Edmonton, Alberta, Canada, October 3, 2023.-- Pacylex Pharmaceuticals, a clinical stage pharmaceutical company focused on the development of therapies for hematologic and solid cancers, announced recent results generated at NIH using its lead drug, zelenirstat, presented at th...